By Dominic ChoppingNovo Nordisk is gradually expanding supply capacity for its blockbuster weight-loss drug, but said it will continue to limit supply of lower-strength doses of the Wegovy medicine in the U.S. as it seeks to safeguard supplies. Write to Dominic Chopping at dominic.chopping@wsj.com

Source: Wall Street Journal November 02, 2023 08:13 UTC